Ultragenyx Pharmaceutical Inc. buy Bank of America Co.
Start price
02.01.26
/
50%
€19.80
Target price
02.01.27
€49.31
Performance (%)
2.02%
Price
05.02.26
€20.80
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ shows slight gains of 2.02%. This prediction currently runs until 02.01.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.970% | 2.970% |
| iShares Core DAX® | -0.197% | -1.724% |
| iShares Nasdaq 100 | -3.612% | -3.768% |
| iShares Nikkei 225® | 1.176% | 2.165% |
| iShares S&P 500 | -0.825% | -1.916% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Bank of America Corporation from $72.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.00
31.05.24
31.05.24
€70.03
31.05.25
31.05.25
-20.00%
01.06.25
01.06.25
